Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-70.41%
operating margin TTM
-3.63%
revenue TTM
315.58 Million
revenue per share TTM
2.19$
valuation ratios | |
|---|---|
| pe ratio | -3.98 |
| peg ratio | 0.47 |
| price to book ratio | 2.45 |
| price to sales ratio | 5.31 |
| enterprise value multiple | -7.94 |
| price fair value | 2.45 |
profitability ratios | |
|---|---|
| gross profit margin | 17.98% |
| operating profit margin | -3.63% |
| pretax profit margin | -126.5% |
| net profit margin | -70.41% |
| return on assets | -16.97% |
| return on equity | -51.07% |
| return on capital employed | -0.93% |
liquidity ratios | |
|---|---|
| current ratio | 6.60 |
| quick ratio | 6.60 |
| cash ratio | 4.83 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 50.11 |
| days of payables outstanding | 0.00 |
| cash conversion cycle | 50.11 |
| receivables turnover | 7.28 |
| payables turnover | 0.00 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.05 |
| debt equity ratio | 0.17 |
| long term debt to capitalization | 0.12 |
| total debt to capitalization | 0.14 |
| interest coverage | -0.25 |
| cash flow to debt ratio | -1.62 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.49 |
| cash per share | 1.50 |
| operating cash flow per share | -0.40 |
| free cash flow operating cash flow ratio | 1.23 |
| cash flow coverage ratios | -1.62 |
| short term coverage ratios | -10.58 |
| capital expenditure coverage ratio | -4.38 |
Frequently Asked Questions
When was the last time Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) reported earnings?
Maravai LifeSciences Holdings, Inc. (MRVI) published its most recent earnings results on 07-11-2025.
What is Maravai LifeSciences Holdings, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)'s trailing twelve months ROE is -51.07%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Maravai LifeSciences Holdings, Inc. (MRVI) currently has a ROA of -16.97%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did MRVI's net profit margin stand at?
MRVI reported a profit margin of -70.41% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is MRVI's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 6.60 in the most recent quarter. The quick ratio stood at 6.60, with a Debt/Eq ratio of 0.17.